Telus Corp (T.TO)

He likes the telcos and prefers BCE. Telcos pay big yields, are stable yields and enjoy an oligopoly in Canada. Shaw is selling to Rogers (pending approval). Quebecor wants spectrum outside Quebec. And all companies are investing heavily in 5G. Once this is complete, the telcos will be golden. He loves this space. Telus is good, but lacks the media assets of BCE, which is a disadvantage.

Usually defaults to BCE for the telecom space. Telus is more aggressive. They are gunning it. The data analysis and AI is their big investment space, instead of content and legacy business. This is probably already priced in.

Benefits whether Shaw deal goes through or not. Either Rogers has wasted a year spinning its wheels, or there will be fewer operators and Shaw was a stiff competitor. Great place to be. Issued debt, so they are cashed up, but this put pressure on the stock. Nice entry point, with still room to move. Yield is 4.68%. (Analysts’ price target is $29.44)

T vs. BCE He'd go with BCE if he had to choose. Telus is more wireless based. BCE also includes media aspects. BCE is a more conservative play, with a dividend of just over 6%. Telus' dividend is just under 5%. When interest rates move down, BCE tends to do better. When interest rates move up, Telus tends to do better. With interest rates tending to moderate this time of year, and markets being a bit softer, he'd go with BCE.

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The company announced a large share sale and this is probably why the share has dropped. Shares are below offer price which should be temporary. A reasonable response to a large deal. Unlock Premium - Try 5i Free

The Rogers-Shaw deal will rotate money out of Shaw into peers like Telus. But what will happen with this deal? Will it be approved? Will there be clauses, if approved? The recent sale of Telus International added cash to their balance sheet. They can grow their dividend at an outsized rate. It pays a good dividend and Telus will attract more capital from the Shaw deal. (Analysts’ price target is $28.98)